Identification of serum proteins associated with response of triple-negative breast cancer to neoadjuvant chemotherapy: preliminary results from the INSTIGO trial
Identification of serum proteins associated with response of triple-negative breast cancer to neoadjuvant chemotherapy: preliminary results from the INSTIGO trial
Xavier Durando, Hugo Veyssière, Ioana Molnar, Yannick Bidet et al.
Journal
Clinical Proteomics
Topics
Advanced Biosensing Techniques and Applications
article
Identification of serum proteins associated with response of triple-negative breast cancer to neoadjuvant chemotherapy: preliminary results from the INSTIGO trial